Displaying drugs 351 - 375 of 406 in total
| Name | Weight | Structure | Desription | Categories |
|---|---|---|---|---|
| Equine Botulinum Neurotoxin E Immune FAB2 | Not Available |  | A mixture of antibodies used to treat documented or suspected botulinum toxin exposure. | Not Available |
| Equine Botulinum Neurotoxin F Immune FAB2 | Not Available | | A mixture of antibodies used to treat documented or suspected botulinum toxin exposure. | Not Available |
| Equine Botulinum Neurotoxin G Immune FAB2 | Not Available | | A mixture of antibodies used to treat documented or suspected botulinum toxin exposure. | Not Available |
| Efbemalenograstim alfa | Not Available | | A granulocyte-colony stimulating factor used to treat prevent chemotherapy-induced neutropenia. | Colony-Stimulating Factors |
| Chorionic Gonadotropin (Human) | Not Available |  | A naturally-occurring hormone produced during human placenta used for the treatment of prepubertal cryptorchidism and hypogonadotropic hypogonadism in selected males, and induction of pregnancy in selected infertile women. | Biological Products / Chorionic Gonadotropin / Fertility Agents, Female / Gonadotropins / Gonadotropins, Pituitary / Placental Hormones / Pregnancy Proteins / Reproductive Control Agents |
| Insulin beef | C254H377N65O75S6 | | Insulin beef has been discontinued in the US and Canada since 2017. | Insulins and Analogues for Injection, Fast-Acting |
| Thyroid, porcine | Not Available | | A naturally-occurring peptide hormone used for the replacement therapy for hypothyroidism of any etiology, treatment for euthyroid goiters, and management of thyroid cancers. | Agents used to treat hypothyroidism / Thyroid Products |
| Luteinizing hormone | Not Annotated | | Not Annotated | Gonadotropins, Pituitary |
| Mecasermin rinfabate | Not Available | | Mecasermin rinfabate was approved for treatment of severe primary insulin-like growth factor (IGF) deficiency or in patients with GH gene deletion who have developed antibodies to growth hormone (GH) .... | Somatropin and Somatropin Agonists |
| Somapacitan | C1038H1609N273O319S9 | | A human growth hormone analog subcutaneous injection indicated for adults with growth hormone deficiency. | Somatropin and Somatropin Agonists |
| Tesamorelin | Not Available | | A growth hormone releasing factor (GRF) analog used to reduce excessive abdominal fat in HIV patients who have developed lipodystrophy. | Somatropin and Somatropin Agonists |
| Corticorelin ovine triflutate | Not Available | | A synthetic corticotropin-releasing hormone used for diagnostic purposes in differentiating pituitary and ectopic production of ACTH in patients with ACTH-dependent Cushing's syndrome. | Tests for Pituitary Function |
| Angiotensin II | Not Available | | A peptide hormone of the RAAS system used to raise blood pressure in septic or other forms of shock. | Angiotensin II, antagonists & inhibitors / Angiotensins / Autacoids / Neuropeptides / Oligopeptides / Peptide Hormones / Vasoconstrictor Agents |
| Sincalide | Not Available | | A diagnostic agent used to stimulate gallbladder contraction or pancreatic secretion during diagnostic tests, and accelerate fluoroscopy and x-ray examination of the intestinal tract. | Tests for Bile Duct Patency |
| Keyhole limpet hemocyanin | Not Available | | Investigated for use/treatment in bladder cancer and solid tumors. | Adjuvants, Immunologic / Antigens / Mollusca |
| Gastric intrinsic factor | Not Available | | Intrinsic factor is not currently available in any FDA or Health Canada approved products. However, it is currently in the marketed (but unapproved) product Hematogen in combination with cyanocobalamin (synthetic... | Intrinsic Factor / Mucoproteins |
| Secretin porcine | Not Annotated | | A secretin hormone used to stimulate pancreatic or gastric secretions to diagnose exocrine pancreas dysfunction, gastrinoma, and abnormalities in the bile and pancreatic ducts. | Gastrointestinal Agents / Secretin |
| Bovine type I collagen | Not Available | | A collagen gel derived from cows used to treat a wide variety of wounds, as well as a supplement for bones and joints. | Allogeneic Cultured Cell Scaffold |
| Epoetin delta | Not Annotated | | Epoetin Delta is an ingredient in the EMA-withdrawn product Dynepo. | Amino Acids, Peptides, and Proteins / Biological Factors / Carbohydrates / Colony-Stimulating Factors / Cytokines / Glycoconjugates / Glycoproteins / Hematopoietic Cell Growth Factors / Intercellular Signaling Peptides and Proteins / Peptides / Proteins |
| Eptotermin alfa | Not Annotated | | A bone morphogenetic protein that is widely expressed during EMBRYONIC DEVELOPMENT. It is both a potent osteogenic factor and a specific regulator of nephrogenesis. Eptotermin alfa is an ingredient in... | Bone Morphogenetic Proteins |
| Dibotermin alfa | Not Available | | indicated for the treatment of acute tibia fractures in adults, as an adjunct to standard care using open fracture reduction and intramedullary unreamed nail fixation [FDA Label]. indicated for single-level... | Bone Morphogenetic Proteins |
| Recombinant Cholera Toxin B Subunit | Not Annotated | | Recombinant Cholera Toxin B Subunit is an ingredient in the EMA-authorised product Dukoral. | Adjuvants, Immunologic / ADP Ribose Transferases / Bacterial Toxins / Cholera Toxin / Enterotoxins / Poisons |
| Neuropeptide Y | Not Annotated | | Neuropeptide Y is under investigation for the basic science of Type 2 Diabetes Mellitus. | Neuropeptide Y, drug effects / Neuropeptides |
| Stem bromelain | Not Available |  | The primary medical purpose for which stem bromelain (SB) is currently indicated for is the removal of eschar in adults with deep partial- and full-thickness thermal burns [FDA Label]. Besides... | Cysteine Endopeptidases / Cysteine Proteases / Endopeptidases / Enzymes / Enzymes and Coenzymes / Hydrolases / Peptide Hydrolases |
| Pepsin | Not Available | | A protease indicated in the treatment of digestive disorders. | Enzyme Preparations |
Displaying drugs 351 - 375 of 406 in total